SAO PAULO (Reuters) - Amgen Inc, the world's biggest biotechnology company, has had a surge in sales in Brazil this year and it plans to double its drug portfolio in the country by the end of the decade, the company's top local executive says.
via Reuters: Health News Read More Here..
No comments:
Post a Comment